Skip to content
RDL Network logo
Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: A Hellenic Co-operative Oncology Group (HeCOG) study — Christos Papadimitriou (2008) | RDL Network